{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:48:45Z","timestamp":1770911325891,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jchromb.2017.10.047","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T16:16:57Z","timestamp":1508775417000},"page":"82-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["An UHPLC\u2013MS\/MS method for simultaneous quantification of human amyloid beta peptides A\u03b21-38, A\u03b21-40 and A\u03b21-42 in cerebrospinal fluid using micro-elution solid phase extraction"],"prefix":"10.1016","volume":"1070","author":[{"given":"Ping-ping","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2017.10.047_bib0005","doi-asserted-by":"crossref","first-page":"7361613","DOI":"10.1155\/2016\/7361613","article-title":"Overview of Alzheimer's disease and some therapeutic approaches targeting abeta by using several synthetic and herbal compounds","volume":"2016","author":"Singh","year":"2016","journal-title":"Oxid. Med. Cell. Longevity"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3233\/JAD-2012-120934","article-title":"Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects","volume":"32","author":"Mattila","year":"2012","journal-title":"J. Alzheimer's Disease"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0015","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0020","first-page":"1869","article-title":"Epidemiology of Alzheimer's disease","volume":"55","author":"Dufouil","year":"2005","journal-title":"La Revue du praticien"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and preclinical Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0030","first-page":"357","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study, The Lancet","volume":"12","author":"Villemagne","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"N. Dominantly Inherited Alzheimer, Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-016-0184-z","article-title":"Impact of frequent cerebrospinal fluid sampling on Abeta levels: systematic approach to elucidate influencing factors","volume":"8","author":"Van Broeck","year":"2016","journal-title":"Alzheimer's Res. Therapy"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00702-012-0801-3","article-title":"Cerebrospinal fluid amyloid-beta 2\u201342 is decreased in Alzheimer's, but not in frontotemporal dementia","volume":"119","author":"Bibl","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.2009.199398","article-title":"CSF amyloid beta38 as a novel diagnostic marker for dementia with Lewy bodies","volume":"82","author":"Mulugeta","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneumeth.2006.03.023","article-title":"Demonstration of a common artifact in immunosorbent assays of brain extracts: development of a solid-phase extraction protocol to enable measurement of amyloid-beta from wild-type rodent brain","volume":"157","author":"Lanz","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0075","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/rcm.2787","article-title":"Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography\/negative electrospray ionization tandem mass spectrometry","volume":"20","author":"Oe","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jchromb.2012.03.032","article-title":"Evaluation of peptide adsorption-controlled liquid chromatography-tandem mass spectrometric (PAC-LC-MS\/MS) method for simple and simultaneous quantitation of amyloid beta 1\u201338 1\u201340, 1\u201342 and 1\u201343 peptides in dog cerebrospinal fluid","volume":"895\u2013896","author":"Goda","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4155\/bio.10.163","article-title":"A screening UHPLC-MS\/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species","volume":"3","author":"Dillen","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0090","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00216-011-5648-1","article-title":"A new methodology for simultaneous quantification of total-Abeta, Abetax-38, Abetax-40, and Abetax-42 by column-switching LC\/MS\/MS","volume":"402","author":"Watanabe","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0095","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s12272-013-0215-2","article-title":"Qualification and application of a liquid chromatography-tandem mass spectrometric method for the determination of human Abeta1-40 and Abeta1-42 peptides in transgenic mouse plasma using micro-elution solid phase extraction","volume":"37","author":"Shin","year":"2014","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jchromb.2017.10.047_bib0105","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jalz.2016.12.004","article-title":"Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease","volume":"13","author":"Lovheim","year":"2017","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ab.2011.08.010","article-title":"Quantitation of amyloid beta peptides Abeta(1\u201338), Abeta(1\u201340), and Abeta(1\u201342) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"419","author":"Lame","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0115","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3233\/JAD-2012-121471","article-title":"A selected reaction monitoring (SRM)-based method for absolute quantification of Abeta38, Abeta40, and Abeta42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls","volume":"33","author":"Pannee","year":"2013","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-132489","article-title":"Qualification of a surrogate matrix-based absolute quantification method for amyloid-beta(4)(2) in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry","volume":"41","author":"Korecka","year":"2014","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000100020","article-title":"Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods","volume":"23","author":"Simonsen","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2012-120082","article-title":"Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease","volume":"31","author":"Wang","year":"2012","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.jchromb.2017.10.047_bib0135","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/pmic.201000511","article-title":"Evaluation of absolute peptide quantitation strategies using selected reaction monitoring","volume":"11","author":"Campbell","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.jchromb.2017.10.047_bib0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1373\/clinchem.2013.220392","article-title":"I.S.D.W.G.o.C. proteins, Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-beta in cerebrospinal fluid","volume":"60","author":"Leinenbach","year":"2014","journal-title":"Clin. Chem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217310838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217310838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T21:27:34Z","timestamp":1570224454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217310838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":28,"alternative-id":["S1570023217310838"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.10.047","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An UHPLC\u2013MS\/MS method for simultaneous quantification of human amyloid beta peptides A\u03b21-38, A\u03b21-40 and A\u03b21-42 in cerebrospinal fluid using micro-elution solid phase extraction","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.10.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}